Frontlight ResearchEarly access
Trial site
Mater Misericordiae Limited
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Ulcerative colitis2 trials
- Autism1 trial
- Cervical cancer1 trial
- COPD1 trial
- Crohn's disease1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche4 trials
- Pfizer2 trials
- Genentech, Inc.1 trial
- Revolution Medicines, Inc.1 trial
- Stalicla SA1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Autism1 recruiting
- COPD1 recruiting
- Crohn's disease1 recruiting
- Lung cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026